| Literature DB >> 23958457 |
T J D Knight-Jones1, J Rushton.
Abstract
Although a disease of low mortality, the global impact of foot and mouth disease (FMD) is colossal due to the huge numbers of animals affected. This impact can be separated into two components: (1) direct losses due to reduced production and changes in herd structure; and (2) indirect losses caused by costs of FMD control, poor access to markets and limited use of improved production technologies. This paper estimates that annual impact of FMD in terms of visible production losses and vaccination in endemic regions alone amount to between US$6.5 and 21 billion. In addition, outbreaks in FMD free countries and zones cause losses of >US$1.5 billion a year. FMD impacts are not the same throughout the world: FMD is highly contagious and the actions of one farmer affect the risk of FMD occurring on other holdings; thus sizeable externalities are generated. Control therefore requires coordination within and between countries. These externalities imply that FMD control produces a significant amount of public goods, justifying the need for national and international public investment. Equipping poor countries with the tools needed to control FMD will involve the long term development of state veterinary services that in turn will deliver wider benefits to a nation including the control of other livestock diseases.Entities:
Keywords: Economics; FMD; Impact; Review
Mesh:
Substances:
Year: 2013 PMID: 23958457 PMCID: PMC3989032 DOI: 10.1016/j.prevetmed.2013.07.013
Source DB: PubMed Journal: Prev Vet Med ISSN: 0167-5877 Impact factor: 2.670
Fig. 1Global burden of FMD in cattle; burden of FMD in sheep and goats had a similar distribution. Measured as a prevalence score based on estimates of incidence, population distribution and other risk factors, adapted from Sumption et al. (2008).
Fig. 2The impacts of foot-mouth-disease (Rushton, 2009).
Estimated FMD vaccinations by country per year [based on the number of vaccine doses produced, as estimated by leading FMD vaccine manufacturers using expert opinion and industry data (Hamond, 2011)] and the population targeted (based on author's consultations and Wint and Robinson (2007)).
| Region | Vaccinations | Population targeted | |||
|---|---|---|---|---|---|
| Doses (millions) | % | Species | Population (millions) | % vaccinated | |
| China | 1600 | 68.1 | Cattle, shoats, pigs and buffalo | 833 | 192.2 |
| India | 150 | 6.4 | Cattle and buffalo | 280 | 53.6 |
| Rest of Asia | 50 | 2.1 | Cattle, pigs and buffalo | 283 | 17.7 |
| Africa | 15 | 0.6 | Cattle | 272 | 5.5 |
| Europe and Turkey | 15 | 0.6 | Cattle | 140 | 10.7 |
| Middle East | 20 | 0.9 | Cattle and shoats | 167 | 12.0 |
| South America | 500 | 21.3 | Cattle | 342 | 146.1 |
| Total | 2350 | 100.0 | 2036 | 115.4 | |
Calculated as the number of vaccine doses × 100/population size; values >100% imply that on average animals were vaccinated more than once a year.
Cost benefit analysis studies of FMD control and eradication programmes.
| Country | Export potential | Returns to control | Analysis | Author |
|---|---|---|---|---|
| Australia | Large | A 6 month outbreak would reduce GDP by 0.6% | Simulation | |
| Australia | Large | Losses to the national economy of $2–3 billion or $8–13 billion can be expected depending on outbreak length | Simulation | |
| Bhutan | Nil | Positive when control focused on endemic areas, negative if unfocussed | Data analysis | |
| Bolivia | Small | Negative, analysis was based on a prolonged programme and reliable data | Data analysis | |
| Bolivia | Small | Positive, but with a short intensive vaccination campaign in the endemic areas | Data analysis | |
| Bolivia | Small | Positive, but control of FMD is not economic for extensive systems, hence greater public funding is required | Data analysis | |
| Botswana | Large | Positive with exports, negative without exports | Data analysis | |
| Canada | Large | Even a small outbreak could cost $2 billion over 5 years | Simulation | |
| France | Large | Rapidly regaining export market access is key, this is best achieved by stamping out | Simulation | |
| UK | At that time small | Positive for both a stamping out policy and for vaccination | Data analysis | |
| India | Small | Positive due to the large returns in the milk sector | Data analysis | |
| Netherlands | Large | Culling is preferable in areas of low livestock density, vaccination is preferable in areas of high density. Market acceptance of products from FMD vaccinated animals reduces the impact of an outbreak | Simulation | |
| Netherlands | Large | The 2001 FMD outbreak cost the nation €1billion | Data analysis | |
| New Zealand | Large | An outbreak could cost $NZ10 billion, with eradication by slaughter being preferable to vaccinate to live | Simulation | |
| Philippines | Unknown | Positive, particularly benefiting the commercial pig sector. Benefit-cost ratio of 1.6–12 depending on level of exports | Data analysis | |
| Sudan | Nil | Positive with increased food security. Benefit-cost ratio of 11.5 with successful vaccination | Data analysis | |
| Southern Cone | Large | Positive for both culling and vaccination strategies, does not deal with social impacts and feasibility of implementation | Data analysis + simulation | |
| Taiwan | Large (pig products to Japan) | Returns according to the information on eradication are large with costs of eradicating the 1997 outbreak estimated to be US$378.9 million, but with potential export losses of approx. US$1.2 billion | Data analysis | |
| Taiwan | Large | Losses due to the 1997 FMD outbreak were experienced in many sectors, causing a 0.28% loss to GDP | Data analysis | |
| Thailand | Possible | Positive with a benefit cost ratio of 3.73 and 15 with and without export of livestock products respectively | Data analysis | |
| Turkey | Unknown | Culling certain highly susceptible cattle could be viable | Data analysis | |
| UK | Large | The lowest cost strategy comparing vaccination to culling depended on other factors, such as outbreak size | Simulation | |
| UK | Large | Vaccination may not be the most effective way of controlling an outbreak, however, speed of regaining export market access is not the only consideration | Data analysis | |
| UK | Large | GDP fell by less than 0.2% due to the 2001 FMD outbreak | Data analysis | |
| USA | Large | Vaccination based eradication provides the best return when the vaccine is effective | Simulation | |
| USA | Large | If time to outbreak detection extends beyond 21 days, every additional hour delay results in extra losses in the order of $565 million | Simulation | |
| USA | Large | A large FMD outbreak could lead to a $14 billion loss in farm income, with loss of exports and fall in demand due to consumer fears | Data analysis | |
| Uruguay | Strong | Control brings strong positive returns based on the access to export markets (20,000 tonnes beef export to USA) | Data analysis | |
| Southern Africa | Strong at that time | Positive benefit, particularly for commercial farms, less so for the poor. Every dollar saved on control leads to $5 lost to the economy | Data analysis |
Fig. 3Density map of FMD susceptible livestock species, i.e. combined cattle, pigs, sheep and goats (Wint and Robinson, 2007; Di Nardo et al., 2011).
Estimated number and cumulative incidence (%) of livestock affected by FMD per year by region. Estimated using FAOSTAT population estimates (Wint and Robinson, 2007) and incidence estimates from Sumption et al. (2008). Outbreaks in free countries excluded. Original estimates are shown without adjustment for uncertainty, except in the bottom two rows where the 5th and 95th percentiles of the uncertainty distribution of total incidence are shown.
| Region | Cattle (thousands) | % | Goats (thousands) | % | Pigs (thousands) | % | Sheep (thousands) | % | Buffalo (thousands) | % |
|---|---|---|---|---|---|---|---|---|---|---|
| cases/population | cases/population | cases/population | cases/population | cases/population | ||||||
| China | 2806/82,815 | 3.39 | 2470/14,360 | 1.72 | 10,965/446,463 | 2.46 | 2347/136,436 | 1.72 | 91/23,272 | 0.39 |
| India | 5912/174,510 | 3.39 | 2163/1,25,732 | 1.72 | 2/13,770 | 0.02 | 1118/64,989 | 1.72 | 411/1,05,127 | 0.39 |
| Rest of Asia | 3550/41,997 | 2.65 | 2454/1,71,556 | 1.43 | 660/86,182 | 0.76 | 1174/1,12,863 | 1.04 | 174/48,292 | 0.36 |
| Africa | 7403/2,71,493 | 2.73 | 4149/2,94,151 | 1.41 | 3/26,555 | 0.01 | 3269/2,89,907 | 1.13 | 0.2/4053 | 0.01 |
| Europe and Turkey | 108/1,40,027 | 0.08 | 29/24,660 | 0.12 | 0/1,91,537 | 0.00 | 121/1,61,070 | 0.07 | 0/422 | 0.02 |
| Middle East | 434/13,770 | 3.15 | 696/47,262 | 1.47 | 0/216 | 0.00 | 1644/1,05,778 | 1.55 | 4/926 | 0.39 |
| South America | 380/3,42,289 | 0.11 | 12/21,220 | 0.06 | 0/55,266 | 0.00 | 37/76,700 | 0.05 | 0/1147 | 0.01 |
| Total | 20,593/1,158,833 | 1.78 | 11,973/8,28,175 | 1.45 | 11,631/8,19,989 | 1.42 | 9709/9,47,743 | 1.02 | 680/1,83,237 | 0.37 |
| 5th percentile | 22,858/1,158,833 | 1.97 | 12,709/8,28,175 | 1.53 | 12,346/8,19,989 | 1.5 | 10,306/9,47,743 | 1.08 | 722/1,83,237 | 0.39 |
| 95th percentile | 61,412/1,158,833 | 5.2 | 35,706/8,28,175 | 4.03 | 34,686/8,19,989 | 4.2 | 28,954/9,47,743 | 3.05 | 2028/1,83,237 | 1.11 |
Global FMD impact due to vaccination costs and direct, visible production losses in affected stock by region; estimated using variable reported vaccination costs, production losses and uncertain FMD incidence. The variation in total impact is shown (90% range) as well as median estimates. Vaccination costs of between US$0.4 and 3 (most likely US$1) per dose and production losses of between US$100 and 370 (most likely US$100) were used. Outbreaks in free countries were not included.
| Impact US$ | ||||
|---|---|---|---|---|
| Production losses | Vaccination | Total | ||
| Region | Median | Median | 90% range | Median |
| China | 1.9 billion | 2.2 billion | 2.5–7 billion | 4 billion |
| India | 1.9 billion | 0.2 billion | 1–4 billion | 2.1 billion |
| Rest of Asia | 1.2 billion | 70 million | 0.7–3 billion | 1.3 billion |
| Africa | 2.3 billion | 20 million | 1–5 billion | 2 billion |
| Europe and Turkey | 35 million | 20 million | 0.03–0.1 billion | 0.06 billion |
| Middle East | 0.2 billion | 30 million | 0.1–0.5 billion | 0.22 billion |
| South America | 0.1 billion | 0.7 billion | 0.5–1.4 billion | 0.8 billion |
| Total | 7.6 billion | 2.5 billion | 6.5–21 billion | 11 billion |
Estimated impact of FMD outbreaks in free countries (S.O. = stamping out).
| Location | Taiwan | Uruguay | UK | Japan | Rep. Korea |
|---|---|---|---|---|---|
| Year | 1997 | 2001 | 2001 | 2010 | 2010–2011 |
| Direct costs | 254 | – | 3558 | 550 | 2780 |
| Indirect costs | 6363 | – | 5646 | N/A | N/A |
| 6617 | 700 | 9204 | >550 | >2780 | |
| Adjusted to value of the US$ in 2011 | 9450 | 880 | 11,600 | >568 | >2870 |
| As percentage of GDP | −0.64% | N/A | −0.20% | N/A | N/A |
| Duration (months) | 4.5 | 4 | 7.5 | 4 | 5 |
| Control method | S.O. + Vacc | S.O. + Vacc | S.O. | S.O. + Vacc | S.O. + Vacc |
| Slaughtered animals | 4 million | 20,000 | 6.24 m | 2,90,000 | 3.47 m |
FAO (2002).
Personal Communication, F. Munzio.
Muroga et al. (2012).
ProMED/Yonhap news agency (2011).
Calculated using contemporary opportunity cost.